# An Investigational Study to Assess the Effect of BMS-986177 on Aspirin in Healthy Participants

> **NCT03341390** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 20 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Aspirin
- **DRUG:** BMS-986177
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03341390
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-18
- **Primary completion:** 2017-11-16
- **Final completion:** 2017-11-16
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2018-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03341390

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03341390, "An Investigational Study to Assess the Effect of BMS-986177 on Aspirin in Healthy Participants". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT03341390. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*